Alpha Tau Medical Ltd (DRTS) Stock Overview
Explore Alpha Tau Medical Ltd’s financial performance, market position, analyst ratings, and future outlook.
Alpha Tau Medical Ltd (DRTS)
Key Financials
Key Financials
Market Cap
1.3B
P/E Ratio
-14.40
EPS (TTM)
$-1.04
ROE
-1.38%
DRTS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Alpha Tau Medical Ltd (NASDAQ: DRTS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Alpha Tau Medical Ltd's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DRTS on the NASDAQ shows an RSI of 66.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.51 for the NASDAQ listing.
Key metrics behind Alpha Tau Medical Ltd's NASDAQ-traded stock include a P/E ratio of -14.40 and a market capitalization of 1.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DRTS on the NASDAQ.